Just as a British firm with a U.S. offshoot won the 1994 Queen's ExportAchievement Award, (see adjoining story), so did a U.S. company'sBritish branch.Genzyme Ltd., of Haverhill, U.K., a wholly owned subsidiary ofGenzyme Corp., of Cambridge, Mass., received the royal accolade for"providing significantly high export figures over the past five years."The firm exports over 80%of its products from Britain to marketsaround the world, notably Germany, Greece, Iran, Syria, Turkey andthe U.S. It recently expanded its manufacturing capacity to producehyaluronic acid, a natural (non-recombinant) biopolymer currently inclinical trials to reduce postoperative adhesions.A letter dated March 23, 1994, embargoed until the Queen's birthday,April 21, officially informed Genzyme Ltd.'s chairman, Geoffrey Cox,that "Her Majesty The Queen has been graciously pleased to approvethe Prime Minister's recommendation that The Queen's Award forExport Achievement should be conferred this year on GenzymeLimited."The letter displays the presentation emblem, which shows two stylizedcogwheels intertwined with four arrows, surmounted by the crown.And, as explained to BioWorld by a press spokesperson at the BritishEmbassy in Washington, "recognition of the whole company'sinvolvement is underlined at the reception for winners hosted by theQueen each year at Buckingham Palace."_David N. Leff
(c) 1997 American Health Consultants. All rights reserved.